Presbyopia Epidemiology Insights

Key Highlights

• According to DelveInsight’s estimates, the total diagnosed prevalent cases of presbyopia in the 7MM, were ~278 million; the number of these cases is expected to increase by 2034.
• In the 7MM, the prevalence of presbyopia is primarily driven by an aging population, lifestyle factors like increased screen time, and advancements in healthcare that promote early diagnosis and treatment. These factors contribute to a growing demand for corrective solutions such as reading glasses, multifocal lenses, and surgical options across the 7MM.
• The age-specific instances of presbyopia in the 7MM were highest for the age group 60–69 (~78 million cases), followed by the age group of less than 60 years (~77 million cases), 70–79 years (~69 million cases), and the age group ≥80 years (~53 million) in 2023.
• According to our analysis, in the 7MM Presbyopia affects both males and females, with nearly 60% of cases occurring in females. 

DelveInsight’s “Presbyopia – Epidemiology Forecast – 2034” report delivers an in-depth understanding of Presbyopia, historical and forecasted epidemiology of Presbyopia in the United States, EU4 (Germany, France, Italy, and Spain) and the United Kingdom, and Japan.

Geography Covered

• The United States
• EU4 (Germany, France, Italy, and Spain) and the United Kingdom
• Japan

Study Period: 2021-2034

Presbyopia Understanding 

Presbyopia Overview

Presbyopia is a common age-related condition characterized by a gradual loss of near-focusing ability, typically becoming noticeable after age 40 and progressing between the ages of 40 and 60. This decline in near vision results from the natural aging process, where the lenses of the eyes lose elasticity due to age-related changes in the proteins within the lens, causing it to thicken, harden, and become less flexible. These changes impair the lens's ability to refract light rays properly, diminishing the eye's focusing capacity. Presbyopia can be categorized into several types, including incipient, functional, absolute, premature, and nocturnal presbyopia. While aging is the primary risk factor for presbyopia, the condition can also manifest prematurely due to factors such as trauma, systemic diseases, cardiovascular conditions, or drug side effects. Early symptoms often include difficulty with prolonged close-up tasks and eye strain, which may worsen in dim light. Other common symptoms encompass delays in focusing at various distances, ocular discomfort, headaches, asthenopia, squinting, fatigue or drowsiness from near work, increased working distance, a need for brighter light when reading, and diplopia. Understanding these mechanisms and symptoms is crucial for the effective management and treatment of presbyopia.

Presbyopia Diagnosis

Diagnosing presbyopia involves a comprehensive eye examination by an ophthalmologist, including assessments of the retina, muscle integrity, refraction, slit-lamp evaluation, visual field, and visual acuity. An ophthalmoscope is used to examine the retina, optic disk, and choroid. Muscle integrity is assessed by observing the patient's ability to follow a moving object. Refractive tests determine how well light waves bend through the cornea and lens to identify the correct lens prescription. A slit-lamp exam provides a magnified view of the eye's anterior structures, while visual field tests measure peripheral vision, and visual acuity tests assess clarity at various distances. Pupil-dilating eye drops may be used, temporarily increasing light sensitivity. These evaluations ensure accurate diagnosis and overall ocular health.

Further details related to diagnosis are provided in the report…

Presbyopia Epidemiology

For the purpose of designing the patient-based model for Presbyopia, the report provides historical as well as forecasted epidemiology segmented by Total Prevalent Cases of Presbyopia, Total Diagnosed Prevalent Cases of Presbyopia, Gender-specific Diagnosed Prevalent Cases of Presbyopia, Age-specific Diagnosed Prevalent Cases of Presbyopia, and Severity-specific Diagnosed Prevalent Cases of Presbyopia, in the 7MM covering the United States, EU4 countries (Germany, France, Italy, and Spain) and the United Kingdom, and Japan, from 2021 to 2034. 

• In the assessment done by DelveInsight, the estimated total prevalent cases of presbyopia in the 7MM were ~325 million in 2023. 
• The highest total diagnosed prevalent cases of Presbyopia were accounted by the US in 2023 (~109 million), which is expected to show a rise in the future.
• Among the European countries, Germany had the highest diagnosed prevalent cases of presbyopia with ~32 million cases, followed by Italy, which had diagnosed prevalent population of ~24 million in 2023. On the other hand, Spain had the lowest diagnosed prevalent population (~18 million cases). 
• Japan had ~50 million total diagnosed prevalent cases of Presbyopia in 2023, accounting for approximately 18% in 7MM.
• In 2023, in the US, the gender-specific diagnosed prevalent cases of presbyopia were highest for females (~60%), as compared to males (~40%), which is attributed to factors such as hormonal differences, ocular anatomy and physiology, lifestyle and occupational factors and others.
• In 2023, presbyopia cases were further sub-segmented based on severity into mild and moderate to severe. Among the 7MM, the highest diagnosed prevalence was observed in moderate to severe, with ~222 million cases, compared to ~56 million mild cases.

KOL Views

To gaze into the epidemiology insights of the real world, we take KOLs and SMEs’ opinions working in the domain through primary research to fill the data gaps and validate our secondary research on disease prevalence. 

DelveInsight’s analysts connected with 20+ KOLs to gather insights; however, interviews were conducted with 10+ KOLs in the 7MM. Centers such as the The Midwest Center for Sight, Des Plaines; University of California, San Francisco; Department of Ophthalmology, Universitätsmedizin, Mannheim; Department of Ophthalmology, University Hospital Morvan; Studi Medici Renna, Melendugno Lecce, Italy; Universidad Miguel Hernandez, Spain; Department of Ophthalmology, Kyorin University School of Medicine, Tokyo; and others were contacted. Their opinion helps understand and validate current disease prevalence, gender involved with the disease, diagnosis rate, and diagnostic criteria.

Explore the evolving Presbyopia Market trends, key players, and future outlook.

Scope of the Report

• The report covers a segment of executive summary, descriptive overview of Presbyopia explaining its causes, signs and symptoms, and currently available diagnostic algorithms and guidelines.
• Comprehensive insight has been provided into the epidemiology segments and forecasts, the future growth potential of diagnosis rate, disease progression, and diagnosis guidelines.
• The report provides an edge for understanding trends, expert insights/KOL views, and patient journeys in the 7MM.
• A detailed review of current challenges in establishing the diagnosis.

Presbyopia Report Insights

• Patient Population
• Country-wise Epidemiology Distribution
• Total Prevalent Cases of Presbyopia
• Total Diagnosed Prevalent Cases of Presbyopia
• Gender-specific Diagnosed Prevalent Cases of Presbyopia
• Age-specific Diagnosed Prevalent Cases of Presbyopia
• Severity-specific Diagnosed Prevalent Cases of Presbyopia

Presbyopia Report Key Strengths

• 11 years Forecast
• The 7MM Coverage 
• Presbyopia Epidemiology Segmentation 
• Presbyopia Report Assessment
• Current Diagnostic Practices Patient Segmentation
• Epidemiology Insights

Key Questions:

• What are the disease risk, burdens, and unmet needs of Presbyopia? What will be the growth opportunities across the 7MM concerning the patient population of Presbyopia?
• What is the historical and forecasted Presbyopia patient pool in the United States, EU4 (Germany, France, Italy, and Spain) and the United Kingdom, and Japan?
• Why is the prevalent cases of Presbyopia in Japan lower than the US?
• Which country has a high patient share for Presbyopia?

Reasons to Buy

• Insights on patient burden/disease, evolution in diagnosis, and factors contributing to the change in the epidemiology of the disease during the forecast years.
• To understand the Presbyopia prevalent cases in varying geographies over the coming years.
• A detailed overview of Gender and Age-specific prevalence of Presbyopia, along with severity-specific prevalence of Presbyopia.
• To understand the perspective of key opinion leaders around the current challenges with establishing the diagnosis options.
• Detailed insights on various factors hampering disease diagnosis and other existing diagnostic challenges.

Frequently Asked Questions

1. What is the forecast period covered in the report?

The Presbyopia Epidemiology report for the 7MM covers the forecast period from 2024 to 2034, providing a projection of epidemiology dynamics and trends during this timeframe.

2. Out of all EU4 countries and the UK, which country had the highest population of Presbyopia cases in 2023?

The highest cases of Presbyopia was found in the Germany among EU4 and the UK in 2023.

3. How is epidemiological data collected and analyzed for forecasting purposes?

Epidemiological data is collected through surveys, clinical studies, health records, and other sources. It is then analyzed to calculate disease rates, identify trends, and project future disease burdens using mathematical models.

4. Out of all 7MM countries, which country had the highest population of Presbyopia cases in 2023?

The highest cases of Presbyopia were found in the US among the 7MM in 2023.